Delivery Order SPE2DB20D1100-SPE2DB24FC8F1

Award Date 7/18/24
Potential Completion Date 8/8/24
Potential Value $7.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of BRUKINSA 80 MG CAPSULE 120S, a specialty pharmaceutical product. The contract has a ceiling value of $7,242.15 and a completion date of October 8, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $7,242.15 firm fixed price contract is for the supply of 4,565,585,855 units of the prescription drug BRUKINSA 80 MG CAPSULE 120S. The contract has an ultimate completion date of September 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a...
This is a $7,242.15 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of BRUKINSA 80 MG CAPSULE 120S, a prescription medication, to support federal healthcare programs. The contract has an ultimate completion date of September 3, 2024 and was awarded on August 12, 2024. This contract is not set aside for any specific business type....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product. The contract has a ceiling value of $14,484.30 and is scheduled for completion by December 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRUKINSA 80 MG CAPSULE 120S. The contract has a total ceiling value of $28,968.60 and an ultimate completion date of December 4, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
The U.S. Defense Logistics Agency (DLA) awarded a $7,242.15 firm-fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of 4565481010 - BRUKINSA 80 MG CAPSULE 120S. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRUKINSA 80 MG CAPSULE 120S, valued at $6,765.08. The contract has an ultimate completion date of August 11, 2023 and is a Firm Fixed Price contract. This appears to be a task order issued under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which is...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,242.15 firm fixed-price delivery order is for the medication BRUKINSA 80 MG CAPSULE 120S, with a completion date of November 6, 2024. The contract was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract, valued at $6,765.08, is for the provision of BRUKINSA 80 MG CAPSULE 120S, a specialty pharmaceutical product. The delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to...
This is a $6,370.00 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of BRUKINSA 80 MG CAPSULE 120S, a medical product, with a period of performance through April 8, 2025. The award is not associated with a set-aside program. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC8F1
    Delivery Order

This is a $7,242.15 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4565190632 BRUKINSA 80 MG CAPSULE 120S. The contract has an ultimate completion date of August 8, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract has no set-aside designation.

Generated 10/17/24, 9:43 AM